The Effect of DBD Plasma Therapy on Wound Healing after Labiaplasty

Bahareh Arbabi^*

Department of Obstetrics and Gynecology, Milad hospital, Isfahan, Iran

Received: 05 June 2024; Accepted: 13 June 2024; Published: 28 June 2024

Citation: Arbabi, Bahareh. “The Effect of DBD Plasma Therapy on Wound Healing after Labiaplasty.” J Gynecol Matern Health (2024): 108. DOI: 10.59462/JGMH.2.1.108

Copyright: © 2024 Arbabi B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Possible risks of labiaplasty: The possible risks include those related to anesthesia,

• bleeding or hematoma (a collection of blood)

• Infection

• Poor scarring, poor incision placement or overactive scarring (it can take 12 to 18 months for scars to fully mature and appear less pink and flat)

• Reduced or increased sensitivity

• Asymmetry

The most common complication is over-resection. While some women desire an aggressive reduction, this can result in chronic dryness, scarring at or near the vaginal opening, and pain during intercourse [1-7]. In addition, some of the common complications of labiaplasty include redness, swelling, itching, discharge, and especially dehiscence after labiaplasty, which are often annoying.

A surgeon needs to control complications. DBD (dielectric barrier discharge) plasma therapy is a typical nonequilibrium high-pressure ac gas discharge which can be a less complicated and safe method in controlling skin complications and accelerating wound healing. DBD plasma therapy was used in the present study for patients who underwent labiaplasty and its effect on the mentioned complications was investigated [8,9].

Study Questions

• How many patients who undergo labiaplasty have wound redness after DBD plasma therapy?

• How many participants have wound secretions after DBD plasma therapy?

• How many patients have a feeling of itching after DBD plasma therapy?

• How many wounds will have dehiscence after DBD plasma therapy?

Methods

The operation site was assessed for redness, secretion and itching on days 7 and 14, and the wound was reassessed for dehiscence until day 21.

Participants

In this quasi-experimental study, 40 patients aged 30- 40 who had undergone trim labiaplasty surgery were recruited.

Inclusion Criteria

None of the participants had medical history, smoking, or medication.

Procedure

DBD plasma therapy was performed on days 3, 7 and 10 after the surgery. Each session lasted for 10 minutes. The operation site was assessed for redness, secretion and itching on days 7 and 14, and the wound was reassessed for dehiscence until day 21 [10-14].

Results

Level of secretions

Following the DBD plasma therapy that started on the 3rd day after the labiaplasty and was repeated on the 7th and 10th days, the wound assessment on the 7th day showed that 2.5% of the women’s wounds had high level of secretions, 20% had moderate level of secretions, and 77% had low secretion, while on the 14th day, these values reached zero, 5% and 95%, respectively; and these changes were statistically significant (P<0.05) [15,16].

Conclusion

Considering the results of this study, DBD plasma therapy can help the surgeon control post-operative wound complications, improve women’s health and subsequently improve their satisfaction with the changes made. Therefore, the use of DBD after surgery can make labiaplasty a satisfactory experience for both the surgeon and the patient.

References

1. Hans-Robert Metelmann, Thomas von Woedtke, Klaus-Dieter Weltmann and Steffen Emmert. “Textbook of Good Clinical Practice in Cold Plasma Therapy.”
2. Fridman, Gregory, Ari D. Brooks, Manjula Balasubramanian  and  Alexander  Fridman,  et al. “Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria.” Plasma Process Polym 4 (2007): 370-375.
3. Laroussi, Mounir. “Nonthermal decontamination of biological media by atmospheric-pressure plasmas: review, analysis and prospects.” IEEE Nucl Plasma Sci Soc 30 (2002): 1409-1415.
4. Uhm, Han S., Jin P. Lim and Shou Z. Li. “Sterilization of bacterial endospores by an atmospheric-pressure argon plasma jet.” Appl Phys Lett 90 (2007).
5. Juwarkar, Chitra Sanjeev. “Cleaning and sterilisation of anaesthetic equipment.” Indian J Anaesth 57 (2013): 541-550.
6. Moisan, M., J. Barbeau, S. Moreau and J. Pelletier, et al. “Low-temperature sterilization using gas plasmas: A review of the experiments and an analysis of the inactivation mechanisms.” Int. J. Pharm 226 (2001): 1-21.
7. Moreau, M., N. Orange and M. G. J. Feuilloley. “Non- thermal plasma technologies: New tools for bio- decontamination.” BiotechnolAdv26 (2008): 610-617.
8. Fridman, Gregory, Alexey Shereshevsky, Monika M. Jost and Ari D. Brooks, et al. “Floating electrode dielectric barrier discharge plasma in air promoting apoptotic behavior in melanoma skin cancer cell lines.” Plasma Chem Plasma Process 27 (2007): 163-176.
9. Stoffels, E., I. E. Kieft and R. E. J. Sladek. “Superficial treatment of mammalian cells using plasma needle.” J Phys D 36 (2003): 2908.
10. Stoffels, E., R. E. J. Sladek and I. E. Kieft. “Gas plasma effects on living cells.” Physica Scripta 2004 (2004): 79.
11. Fridman, Gregory, Marie Peddinghaus, Manjula Balasubramanian and Halim Ayan, et al. “Blood coagulation and living tissue sterilization by floating- electrode dielectric barrier discharge in air.” Plasma Chem Plasma Process 26 (2006): 425-442.
12. Fridman, Gregory, Gary Friedman, Alexander Gutsol and Anatoly B. Shekhter, et al. “Applied plasma medicine.” Plasma Process Polym 5 (2008): 503-533.
13. Ben Belgacem, Zouhaier, Gaëlle Carré, Emilie Charpentier and Florian Le-Bras, et al. “Innovative non-thermal plasma disinfection process inside sealed bags: Assessment of bactericidal and sporicidal effectiveness regarding current sterilization norms.” PLoS One 12 (2017): e0180183.
14. Vaillant, Jaqueline Dranguet, Angela Fraga, María Teresa Díaz and A. Mallok, et al. “Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats.” Eur J Pharmacol 714 (2013): 318-324.
15. Lunov, Oleg, Vitalii Zablotskii, Olexander Churpita and Eliška Chánová, et al. “Cell death induced by ozone and various non-thermal plasmas: therapeutic perspectives and limitations.” Sci Rep 4 (2014): 7129.
16. Jha, Nayansi, Jae Jun Ryu, Eun Ha Choi and Nagendra Kumar Kaushik. “Generation and role of reactive oxygen and nitrogen species induced by plasma, lasers, chemical agents and other systems in dentistry.” Oxid Med Cell 2017 (2017): 7542540.